Andrographolide attenuates skeletal muscle dystrophy in mdx mice and increases efficiency of cell therapy by reducing fibrosis

BACKGROUND: Duchenne muscular dystrophy (DMD) is characterized by the absence of the cytoskeletal protein dystrophin, muscle wasting, increased transforming growth factor type beta (TGF-β) signaling, and fibrosis. At the present time, the only clinically validated treatments for DMD are glucocortico...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabrera, Daniel, Gutiérrez, Jaime, Cabello-Verrugio, Claudio, Morales, Maria Gabriela, Mezzano, Sergio, Fadic, Ricardo, Casar, Juan Carlos, Hancke, Juan L, Brandan, Enrique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021597/
https://www.ncbi.nlm.nih.gov/pubmed/24655808
http://dx.doi.org/10.1186/2044-5040-4-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021597/
https://www.ncbi.nlm.nih.gov/pubmed/24655808
http://dx.doi.org/10.1186/2044-5040-4-6

Ejemplares similares